In a cohort of 91 MM patients, 18% of cases show TSC1 loss-of-function mutations which plays a suppressive role in cellular proliferation initiated by mTOR (109) and a similar result also showed in a recently published meta-analysis review of MM (105). The gene discussed is MTOR; the disease is Miyoshi myopathy.